LAG3 limits regulatory T cell proliferation and function in autoimmune diabetes

Science Immunology

Volumn 2, Issue 9, 2017, Pages

  Zhang, Qianxia ^a,b   Chikina, Maria ^a   Szymczak Workman, Andrea L ^a,b   Horne, William ^c   Kolls, Jay K ^c   Vignali, Kate M ^a,b   Normolle, Daniel ^d   Bettini, Maria ^b,f   Workman, Creg J ^a,b   Vignali, Dario A A ^a,b,e  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85029769836     PISSN: None     EISSN: 24709468     Source Type: Journal    
DOI: 10.1126/sciimmunol.aah4569     Document Type: Article

References (51)

1. Q. Zhang, D. A. A. Vignali, Co-stimulatory and co-inhibitory pathways in autoimmunity. Immunity 44, 1034–1051 (2016).
2. M. K. Callahan, M. A. Postow, J. D. Wolchok, Targeting T cell co-receptors for cancer therapy. Immunity 44, 1069–1078 (2016).
3. S. L. Topalian, C. G. Drake, D. M. Pardoll, Immune checkpoint blockade: A common denominator approach to cancer therapy. Cancer Cell 27, 450–461 (2015).
4. A. C. Anderson, N. Joller, V. K. Kuchroo, Lag-3, Tim-3, and TIGIT: Co-inhibitory receptors with specialized functions in immune regulation. Immunity 44, 989–1004 (2016).
5. C. J. Workman, D. A. A. Vignali, The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated T cells. Eur. J. Immunol. 33, 970–979 (2003).
6. C. J. Workman, L. S. Cauley, I.-J. Kim, M. A. Blackman, D. L. Woodland, D. A. A. Vignali, Lymphocyte activation gene-3 (CD223) regulates the size of the expanding T cell population following antigen activation in vivo. J. Immunol. 172, 5450–5455 (2004).
7. C. J. Workman, D. A. A. Vignali, Negative regulation of T cell homeostasis by lymphocyte activation gene-3 (CD223). J. Immunol. 174, 688–695 (2005).
8. M. Bettini, A. L. Szymczak-Workman, K. Forbes, A. H. Castellaw, M. Selby, X. Pan, C. G. Drake, A. J. Korman, D. A. A. Vignali, Cutting edge: Accelerated autoimmune diabetes in the absence of LAG-3. J. Immunol. 187, 3493–3498 (2011).
9. S.-R. Woo, M. E. Turnis, M. V. Goldberg, J. Bankoti, M. Selby, C. J. Nirschl, M. L. Bettini, D. M. Gravano, P. Vogel, C. L. Liu, S. Tangsombatvisit, J. F. Grosso, G. Netto, M. P. Smeltzer, A. Chaux, P. J. Utz, C. J. Workman, D. M. Pardoll, A. J. Korman, C. G. Drake, D. A. A. Vignali, Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape. Cancer Res. 72, 917–927 (2012).
10. + T cell accumulation and effector function in murine self- and tumor-tolerance systems. J. Clin. Invest. 117, 3383–3392 (2007).
11. C.-T. Huang, C. J. Workman, D. Flies, X. Pan, A. L. Marson, G. Zhou, E. L. Hipkiss, S. Ravi, J. Kowalski, H. I. Levitsky, J. D. Powell, D. M. Pardoll, C. G. Drake, D. A. A. Vignali, Role of LAG-3 in regulatory T cells. Immunity 21, 503–513 (2004).
12. N. Gagliani, C. F. Magnani, S. Huber, M. E. Gianolini, M. Pala, P. Licona-Limon, B. Guo, D. R. Herbert, A. Bulfone, F. Trentini, C. Di Serio, R. Bacchetta, M. Andreani, L. Brockmann, S. Gregori, R. A. Flavell, M.-G. Roncarolo, Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat. Med. 19, 739–746 (2013).
13. B. Liang, C. Workman, J. Lee, C. Chew, B. M. Dale, L. Colonna, M. Flores, N. Li, E. Schweighoffer, S. Greenberg, V. Tybulewicz, D. Vignali, R. Clynes, Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. J. Immunol. 180, 5916–5926 (2008).
14. F. A. Schildberg, S. R. Klein, G. J. Freeman, A. H. Sharpe, Coinhibitory pathways in the B7-CD28 ligand-receptor family. Immunity 44, 955–972 (2016).
15. D. A. A. Vignali, L. W. Collison, C. J. Workman, How regulatory T cells work. Nat. Rev. Immunol. 8, 523–532 (2008).
16. S. Sakaguchi, T. Yamaguchi, T. Nomura, M. Ono, Regulatory T cells and immune tolerance. Cell 133, 775–787 (2008).
17. G. M. Delgoffe, S.-R. Woo, M. E. Turnis, D. M. Gravano, C. Guy, A. E. Overacre, M. L. Bettini, P. Vogel, D. Finkelstein, J. Bonnevier, C. J. Workman, D. A. A. Vignali, Stability and function of regulatory T cells is maintained by a neuropilin-1–semaphorin-4a axis. Nature 501, 252–256 (2013).
18. M. Feuerer, Y. Shen, D. R. Littman, C. Benoist, D. Mathis, How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. Immunity 31, 654–664 (2009).
19. S. L. Bailey-Bucktrout, M. Martinez-Llordella, X. Zhou, B. Anthony, W. Rosenthal, H. Luche, H. J. Fehling, J. A. Bluestone, Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response. Immunity 39, 949–962 (2013).
20. + T regulatory cells in NZW mice. Proc. Natl. Acad. Sci. U.S.A. 113, 1345–1350 (2016).
21. + T cells into TH17 cells in autoimmune arthritis. Nat. Med. 20, 62–68 (2014).
22. Q. Tang, J. Y. Adams, C. Penaranda, K. Melli, E. Piaggio, E. Sgouroudis, C. A. Piccirillo, B. L. Salomon, J. A. Bluestone, Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28, 687–697 (2008).
23. J. C. Reed, K. C. Herold, Thinking bedside at the bench: The NOD mouse model of T1DM. Nat. Rev. Endocrinol. 11, 308–314 (2015).
24. N. Li, Y. Wang, K. Forbes, K. M. Vignali, B. S. Heale, P. Saftig, D. Hartmann, R. A. Black, J. J. Rossi, C. P. Blobel, P. J. Dempsey, C. J. Workman, D. A. A. Vignali, Metalloproteases regulate T-cell proliferation and effector function via LAG-3. EMBO J. 26, 494–504 (2007).
25. N. Li, C. J. Workman, S. M. Martin, D. A. A. Vignali, Biochemical analysis of the regulatory T cell protein lymphocyte activation gene-3 (LAG-3; CD223). J. Immunol. 173, 6806–6812 (2004).
26. G. P. Lennon, M. Bettini, A. R. Burton, E. Vincent, P. Y. Arnold, P. Santamaria, D. A. A. Vignali, T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event. Immunity 31, 643–653 (2009).
27. P. Marrack, J. Kappler, Control of T cell viability. Annu. Rev. Immunol. 22, 765–787 (2004).
28. + regulatory T cells during experimental autoimmune encephalomyelitis. Eur. J. Immunol. 43, 1195–1207 (2013).
29. + regulatory T cells in islets of nonobese diabetic mice. J. Immunol. 188, 1064–1074 (2012).
30. A. M. D’Alise, V. Auyeung, M. Feuerer, J. Nishio, J. Fontenot, C. Benoist, D. Mathis, The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors. Proc. Natl. Acad. Sci. U.S.A. 105, 19857–19862 (2008).
31. W. Fu, A. Ergun, T. Lu, J. A. Hill, S. Haxhinasto, M. S. Fassett, R. Gazit, S. Adoro, L. Glimcher, S. Chan, P. Kastner, D. Rossi, J. J. Collins, D. Mathis, C. Benoist, A multiply redundant genetic switch ‘locks in’ the transcriptional signature of regulatory T cells. Nat. Immunol. 13, 972–980 (2012).
32. + regulatory T cells. Science 325, 1142–1146 (2009).
33. + T helper cells is controlled by the transcription factor Eos. Immunity 38, 998–1012 (2013).
34. N. Ohkura, M. Hamaguchi, H. Morikawa, K. Sugimura, A. Tanaka, Y. Ito, M. Osaki, Y. Tanaka, R. Yamashita, N. Nakano, J. Huehn, H. J. Fehling, T. Sparwasser, K. Nakai, S. Sakaguchi, T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. Immunity 37, 785–799 (2012).
35. J. D. Fontenot, J. P. Rasmussen, M. A. Gavin, A. Y. Rudensky, A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6, 1142–1151 (2005).
36. + regulatory T cells in the absence of interleukin 2 signaling. Nat. Immunol. 6, 1152–1159 (2005).
37. A. Gonzalez, J. D. Katz, M.-G. Mattei, H. Kikutani, C. Benoist, D. Mathis, Genetic control of diabetes progression. Immunity 7, 873–883 (1997).
38. +Treg and suppresses type 1 diabetes in NOD mice. Diabetes 62, 3775–3784 (2013).
39. Y. Grinberg-Bleyer, A. Baeyens, S. You, R. Elhage, G. Fourcade, S. Gregoire, N. Cagnard, W. Carpentier, Q. Tang, J. Bluestone, L. Chatenoud, D. Klatzmann, B. L. Salomon, E. Piaggio, IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells. J. Exp. Med. 207, 1871–1878 (2010).
40. J. G. Markle, D. N. Frank, S. Mortin-Toth, C. E. Robertson, L. M. Feazel, U. Rolle-Kampczyk, M. von Bergen, K. D. McCoy, A. J. Macpherson, J. S. Danska, Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339, 1084–1088 (2013).
41. L. Yurkovetskiy, M. Burrows, A. A. Khan, L. Graham, P. Volchkov, L. Becker, D. Antonopoulos, Y. Umesaki, A. V. Chervonsky, Gender bias in autoimmunity is influenced by microbiota. Immunity 39, 400–412 (2013).
42. B. Zhang, S. Chikuma, S. Hori, S. Fagarasan, T. Honjo, Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model. Proc. Natl. Acad. Sci. U.S.A. 113, 8490–8495 (2016).
43. X. Zhou, L. T. Jeker, B. T. Fife, S. Zhu, M. S. Anderson, M. T. McManus, J. A. Bluestone, Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J. Exp. Med. 205, 1983–1991 (2008).
44. T. Miyazaki, A. Dierich, C. Benoist, D. Mathis, Independent modes of natural killing distinguished in mice lacking Lag3. Science 272, 405–408 (1996).
45. C. A. Steward, J. M. Gonzalez, S. Trevanion, D. Sheppard, G. Kerry, J. G. R. Gilbert, L. S. Wicker, J. Rogers, J. L. Harrow, The non-obese diabetic mouse sequence, annotation and variation resource: An aid for investigating type 1 diabetes. Database 2013, bat032 (2013).
46. E. H. Leiter, The NOD mouse: A model for insulin-dependent diabetes mellitus. Curr. Protoc. Immunol. chap. 15, 10.1002/0471142735.im1509s24 (2001).
47. A. N. McMurchy, M. K. Levings, Suppression assays with human T regulatory cells: A technical guide. Eur. J. Immunol. 42, 27–34 (2012).
48. C. Trapnell, L. Pachter, S. L. Salzberg, TopHat: Discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105–1111 (2009).
49. C. Trapnell, B. A. Williams, G. Pertea, A. Mortazavi, G. Kwan, M. J. van Baren, S. L. Salzberg, B. J. Wold, L. Pachter, Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511–515 (2010).
50. M. I. Love, W. Huber, S. Anders, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
51. K. D. Hansen, R. A. Irizarry, Z. Wu, Removing technical variability in RNA-seq data using conditional quantile normalization. Biostatistics 13, 204–216 (2012).